Toggle navigation
Home
Submit
Login
Toggle navigation
Recent submissions
edepositIreland
School of Pharmacy and Pharmaceutical Sciences
Pharmacy and Pharmaceutical Sciences
Pharmacy and Pharmaceutical Sciences (Scholarly Publications)
Recent submissions
edepositIreland
School of Pharmacy and Pharmaceutical Sciences
Pharmacy and Pharmaceutical Sciences
Pharmacy and Pharmaceutical Sciences (Scholarly Publications)
Recent submissions
JavaScript is disabled for your browser. Some features of this site may not work without it.
Search DSpace
This Collection
Browse
All of TARA
edepositIreland Collections
Titles
Authors
Date of Publication
Subjects
Sponsor
This Collection
Titles
Authors
Date of Publication
Subjects
Sponsor
My Account
Login
Pharmacy and Pharmaceutical Sciences (Scholarly Publications): Recent submissions
Now showing items 281-300 of 452
Matrix metalloproteinase expression and production by alveolar macrophages in emphysema.
O'DRISCOLL, LORRAINE
(
1997
)
Intracellular and extracellular microRNAs in breast cancer.
O'DRISCOLL, LORRAINE
(
2011
)
Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells.
O'Driscoll, Lorraine
(
2014
)
Expanding on Exosomes and Ectosomes in Cancer
O'Driscoll, Lorraine
(
2015
)
Dairy proteins, dairy lipids, and postprandial lipemia in persons with abdominal obesity (DairyHealth): a 12-wk, randomized, parallel-controlled, double-blinded, diet intervention study.
O'Driscoll, Lorraine
(
2015
)
Can exosomes influence triple negative breast cancer metastasis?
O'Driscoll, Lorraine
(
2012
)
Exosomes: potential regulators and biomarkers of prostate cancer progression.
O'Driscoll, Lorraine
(
2012
)
The Relevance of exosomal-miRNAs in triple-negative breast cancer progression.
O'Driscoll, Lorraine
(
2013
)
miR-134 transported in extracellular vesicles reduces triple-negative breast cancer aggression.
O'Driscoll, Lorraine
(
2014
)
miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
O'Driscoll, Lorraine
(
2014
)
Effect of acquired resistance to lapatinib in HER2-positive breast cancer cells on the Bcl-2 family members MCL-1 and BAX.
O'Driscoll, Lorraine
(
2012
)
Neuromedin U: A potential predictive biomarker for HER2-targeted drugs.
O'Driscoll, Lorraine
(
2012
)
Assessment of neratinib-resistance and cross-resistance in HER2-overexpressing breast cancer cells.
O'Driscoll, Lorraine
(
2013
)
Feasibility and relevance of global expression profiling of gene transcripts in serum from breast cancer patients using whole genome microarrays and quantitative RT-PCR.
O'DRISCOLL, LORRAINE
(
2008
)
Molecular medicine of microRNAs: structure, function and implications for diabetes.
O'Driscoll, Lorraine
(
2008
)
SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue.
O'DRISCOLL, LORRAINE
(
2008
)
Extracellular nucleic acids and their potential as diagnostic, prognostic and predictive biomarkers.
O'DRISCOLL, LORRAINE
(
2007
)
A microarray approach to translational medicine in breast cancer: how representative are cell line models of clinical conditions?
O'DRISCOLL, LORRAINE
(
2007
)
MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer.
O'DRISCOLL, LORRAINE
(
2007
)
MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma.
O'DRISCOLL, LORRAINE
(
2007
)
